Published in J R Soc Interface on June 06, 2008
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol (2009) 8.13
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet (2009) 6.96
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A (2009) 2.78
Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med (2012) 2.54
Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulm Med (2013) 1.98
Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis. BMJ (2011) 1.80
Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis. Sci Transl Med (2012) 1.65
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. Proc Natl Acad Sci U S A (2012) 1.48
The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med (2016) 1.32
Priorities for tuberculosis research: a systematic review. Lancet Infect Dis (2010) 1.22
Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discov Today (2011) 1.21
Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med (2014) 1.11
Risk Factors of Active Tuberculosis in People Living with HIV/AIDS in Southwest Ethiopia: A Case Control Study. Ethiop J Health Sci (2011) 1.10
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am J Respir Crit Care Med (2012) 1.09
Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One (2013) 1.06
Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS One (2012) 1.04
Childhood TB Surveillance: Bridging the Knowledge Gap to Inform Policy. J Trop Med (2012) 1.02
Discriminating active from latent tuberculosis in patients presenting to community clinics. PLoS One (2012) 1.01
Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proc Natl Acad Sci U S A (2008) 1.00
Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected mice. Antimicrob Agents Chemother (2012) 0.96
Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice. Antimicrob Agents Chemother (2014) 0.96
Modeling socio-demography to capture tuberculosis transmission dynamics in a low burden setting. J Theor Biol (2011) 0.95
The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. PLoS One (2014) 0.95
After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci (2014) 0.94
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions. PLoS Med (2016) 0.92
Civil Surgeon Tuberculosis Evaluations for Foreign-Born Persons Seeking Permanent U.S. Residence. J Immigr Minor Health (2016) 0.90
The next 10 years for tuberculosis vaccines: do we have the right plans in place? Expert Rev Vaccines (2013) 0.90
The impact of realistic age structure in simple models of tuberculosis transmission. PLoS One (2010) 0.88
Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil. PLoS One (2013) 0.88
Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J Infect Dis (2011) 0.87
Predicting U.S. tuberculosis case counts through 2020. PLoS One (2013) 0.85
The roles of immune memory and aging in protective immunity and endogenous reactivation of tuberculosis. PLoS One (2013) 0.81
A new compartmental model of Mycobacterium avium subsp. paratuberculosis infection dynamics in cattle. Prev Vet Med (2015) 0.81
Evaluation of gamma interferon immune response elicited by the newly constructed PstS-1(285-374):CFP10 fusion protein to detect Mycobacterium tuberculosis infection. Clin Vaccine Immunol (2014) 0.80
Cost-effectiveness of rifampin for 4 months and isoniazid for 9 months in the treatment of tuberculosis infection. Eur J Clin Microbiol Infect Dis (2012) 0.79
Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults. Vaccine (2014) 0.79
Modelling challenges in context: lessons from malaria, HIV, and tuberculosis. Epidemics (2015) 0.78
Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines. Hum Vaccin Immunother (2016) 0.78
The effects of progressing and nonprogressing Mycobacterium avium ssp. paratuberculosis infection on milk production in dairy cows. J Dairy Sci (2015) 0.78
Dynamics of Mycobacterium and bovine tuberculosis in a human-buffalo population. Comput Math Methods Med (2014) 0.76
A review of clinical models for the evaluation of human TB vaccines. Hum Vaccin Immunother (2016) 0.75
The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus. J Prev Med Hyg (2017) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet (2006) 7.82
Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet (1998) 6.94
Global epidemiology of tuberculosis. Lancet (2006) 6.70
Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis (2007) 6.41
Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med (2004) 5.90
WHO's new Stop TB Strategy. Lancet (2006) 5.59
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet (2006) 4.73
The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med (1995) 4.60
The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol (2005) 4.52
An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med (2006) 4.28
The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect (1997) 3.97
Control strategies for tuberculosis epidemics: new models for old problems. Science (1996) 3.59
Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A (1998) 3.22
Tuberculosis: a problem with persistence. Nat Rev Microbiol (2003) 3.17
New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn (2006) 2.89
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science (2002) 2.65
Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci U S A (2000) 2.46
Tuberculosis control in the era of HIV. Nat Rev Immunol (2005) 2.40
The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med (2007) 2.39
New measurable indicator for tuberculosis case detection. Emerg Infect Dis (2004) 2.34
The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis (2003) 2.17
Targets for global tuberculosis control. Int J Tuberc Lung Dis (2006) 2.16
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med (2006) 1.55
The development and impact of tuberculosis vaccines. Cell (2006) 1.50
The long-term dynamics of tuberculosis and other diseases with long serial intervals: implications of and for changing reproduction numbers. Epidemiol Infect (1998) 1.19
Trends in the prevalence and incidence of tuberculosis in south India. Int J Tuberc Lung Dis (2001) 1.09
BCG in immunization programmes. Wkly Epidemiol Rec (2001) 0.80
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med (2009) 5.93
Global incidence of multidrug-resistant tuberculosis. J Infect Dis (2006) 5.42
The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis (2003) 5.09
The population dynamics and control of tuberculosis. Science (2010) 5.08
Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS (2003) 4.87
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health (2007) 4.13
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82
Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One (2011) 3.57
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44
Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health (2008) 3.32
Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn (2007) 3.31
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med (2004) 3.26
Tuberculosis incidence in prisons: a systematic review. PLoS Med (2010) 2.96
AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS (2009) 2.92
Impact of malaria control on childhood anaemia in Africa -- a quantitative review. Trop Med Int Health (2004) 2.80
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science (2002) 2.65
Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis (2003) 2.49
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis (2002) 2.33
A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol (2009) 2.20
Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS (2003) 2.11
Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC Public Health (2005) 2.09
Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data. Lancet (2013) 2.03
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
What is the limit to case detection under the DOTS strategy for tuberculosis control? Tuberculosis (Edinb) (2003) 1.72
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS One (2008) 1.61
Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count? Bull World Health Organ (2009) 1.59
Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One (2011) 1.51
Preventing HIV transmission with antiretrovirals. Bull World Health Organ (2009) 1.50
High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr (2002) 1.43
The unexplored story of HIV and ageing. Bull World Health Organ (2009) 1.34
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31
The benefits of early treatment for HIV. AIDS (2010) 1.11
Role of acute infection in HIV transmission. Lancet (2011) 0.98
Slow elimination of multidrug-resistant tuberculosis. Sci Transl Med (2009) 0.96
Cost-effectiveness of antiretroviral therapy for prevention. Curr HIV Res (2011) 0.95
Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in kenya. AIDS Res Treat (2012) 0.92
Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe. Epidemics (2011) 0.88
Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. Am J Respir Crit Care Med (2002) 0.88
Impact of HIV on novel therapies for tuberculosis control. AIDS (2008) 0.87
Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic. Curr HIV/AIDS Rep (2014) 0.85
Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives? HIV AIDS (Auckl) (2011) 0.81
Incongruent HIV and tuberculosis co-dynamics in Kenya: interacting epidemics monitor each other. Epidemics (2008) 0.80
Evaluating outcomes of the President's Emergency Plan for AIDS Relief in Africa. Ann Intern Med (2010) 0.76
The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: the modeling approach. J Acquir Immune Defic Syndr (2014) 0.75
Consequences of early treatment for individuals at risk of human immunodeficiency virus infection. Clin Infect Dis (2009) 0.75